Paul Clark
Chief Executive Officer bei Lilly ICOS LLC
Profil
Paul N. Clark ist ein unabhängiger Director bei Agenus, Inc. und ein leitender unabhängiger Non-Executive Director bei Keysight Technologies, Inc. sowie ein unabhängiger Director bei Agilent Technologies, Inc. und ein President & Chief Executive Officer bei Lilly ICOS LLC. Er ist Mitglied des Board of Directors von Agenus, Inc., Keysight Technologies, Inc., Agilent Technologies, Inc. und Grifols Therapeutics, Inc. Herr Clark war zuvor als unabhängiger Direktor bei Amylin Pharmaceuticals, Inc. beschäftigt, als Operating Partner bei Genstar Capital LLC, als Vorsitzender bei ICOS Corp., als Direktor & Executive Vice President bei Abbott Laboratories, als Vice President-Sales & Marketing bei Marion Laboratories und als Operating Partner & Advisor bei Genstar Capital Management LLC. Außerdem war er Vorstandsmitglied bei BIOLASE, Inc. und Talecris Biotherapeutics Holdings Corp. sowie bei Catalent Pharma Solutions, Inc. und Cerevast Neurorehab, Inc. und Harlan Laboratories, Inc. Er erhielt seinen Bachelor-Abschluss von der University of Alabama und einen MBA von der Tuck School of Business in Dartmouth.
Aktive Positionen von Paul Clark
| Unternehmen | Position | Beginn |
|---|---|---|
Lilly ICOS LLC
 Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Lilly ICOS LLC develops and markets medical drugs. It produces Cialis drug which is used for the treatment of erectile dysfunction. The firm's competitors are Viagra and Levitra. The company was founded in October 1998 and is headquartered in Indianapolis, IN. | Chief Executive Officer | - |
Grifols Therapeutics, Inc.
 Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 27.10.2011 |
Ehemalige bekannte Positionen von Paul Clark
| Unternehmen | Position | Ende |
|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Director/Board Member | 21.12.2021 |
| KEYSIGHT TECHNOLOGIES, INC. | Chairman | 01.10.2019 |
| AGENUS INC. | Director/Board Member | 15.06.2021 |
| BIOLASE, INC. | Chairman | 01.09.2017 |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Director/Board Member | 01.09.2014 |
Ausbildung von Paul Clark
| The University of Alabama | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| BIOLASE, INC. | Health Technology |
| AGILENT TECHNOLOGIES, INC. | Health Technology |
| AGENUS INC. | Health Technology |
| KEYSIGHT TECHNOLOGIES, INC. | Electronic Technology |
| CATALENT, INC. | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Genstar Capital Management LLC
 Genstar Capital Management LLC Investment ManagersFinance Genstar Capital Management LLC is a private equity firm founded in 1988 by Dennis H. Chookaszian. The firm is headquartered in San Francisco., California. | Finance |
Lilly ICOS LLC
Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Lilly ICOS LLC develops and markets medical drugs. It produces Cialis drug which is used for the treatment of erectile dysfunction. The firm's competitors are Viagra and Levitra. The company was founded in October 1998 and is headquartered in Indianapolis, IN. | Health Technology |
Cerevast Medical, Inc.
 Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Finance |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | Health Technology |
Talecris Biotherapeutics Holdings Corp.
 Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Health Technology |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
| Marion Laboratories | Distribution Services |
Harlan Laboratories, Inc.
 Harlan Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Harlan Laboratories, Inc. provided essential, pre-clinical and non-clinical contract research, research models, lab animal diets and services. The firm's focused on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. The company was founded in 1931 and was headquartered in Indianapolis, IN. | Commercial Services |
Genstar Capital LLC
 Genstar Capital LLC Investment ManagersFinance Genstar Capital LLC engages in provision of investment consulting services. It offers investment advice to financial services, healthcare, industrial, and technology and software industries. The company was founded in 1988 and is headquartered in San Francisco, CA. | Finance |
